institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Texas Invests $50 Million in Ibogaine Research for Addiction Treatment, Advocates Still Eye Tri-State

  • Texas Gov. Greg Abbott signed Senate Bill 2308 on Wednesday to invest $50 million in clinical research on ibogaine in Austin, Texas.
  • The bill establishes a collaborative partnership among academic institutions, medical centers, and pharmaceutical companies to carry out FDA-approved clinical trials investigating ibogaine’s therapeutic effects on addiction and PTSD.
  • Supporting research includes a 2024 Stanford Medical study where 30 veterans treated with ibogaine and magnesium showed nearly 90% symptom reduction in PTSD, depression, and anxiety.
  • Abbott said ibogaine shows "great promise" for addiction and mental health, with Texas leading nationwide evaluation, while Republicans find it easier to support due to its medical intent.
  • Texas will retain a 20% stake in successful ibogaine drugs developed and allocate 25% of revenues to veteran programs, establishing the state as a global leader in psychedelic research funding.
Insights by Ground AI
Does this summary seem wrong?

23 Articles

All
Left
4
Center
13
Right
1
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 72% of the sources are Center
72% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Washington Post broke the news in on Monday, June 9, 2025.
Sources are mostly out of (0)